18.04.2023 Gerresheimer AG  DE000A0LD6E6

EQS-Adhoc: Gerresheimer AG: Gerresheimer AG launches cash capital increase with exclusion of shareholders' subscription rights through accelerated bookbuilding by up to 3,140,000 shares


 

EQS-Ad-hoc: Gerresheimer AG / Key word(s): Capital Increase
Gerresheimer AG: Gerresheimer AG launches cash capital increase with exclusion of shareholders' subscription rights through accelerated bookbuilding by up to 3,140,000 shares

18-Apr-2023 / 17:49 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN OR OTHER COUNTRIES WHERE SUCH A PUBLICATION COULD BE UNLAWFUL

Duesseldorf, April 18, 2023 – Today, the management board of Gerresheimer AG (ISIN DE000A0LD6E6), with the approval of the supervisory board, resolved to launch a capital increase against cash contributions with exclusion of subscription rights through partial utilization of its authorized capital. The share capital of the company will be increased by issuance of up to 3,140,000 new no-par value bearer shares.

The share placement will launch with immediate effect and the new shares will be exclusively offered for sale to institutional investors as part of an international private placement by way of an accelerated bookbuilding. The placement price and the number of shares to be issued will be determined immediately after such bookbuilding. The new shares will carry dividend rights for the 2021/2022 financial year as announced of EUR 1.25 per share.

Admission of the new shares to trading in the sub-segment of the regulated market with additional post-admission obligations (Prime Standard) on the Frankfurt Stock Exchange is expected to take place without a prospectus on April 21, 2023. Trading is expected to commence on April 24, 2023. It is intended to include the new shares in the existing quotation for the Company's shares. The delivery of the new shares is expected to occur on or around April 24, 2023.

The net proceeds from the capital increase will provide the company with the flexibility to further capture significant incremental growth opportunities with a particular focus on High Value Solutions and Medical Devices including biological solutions such as GLP-1 related treatments.

As part of the transaction, Gerresheimer has agreed to a lock-up, i.e., an obligation not to, inter alia, issue further shares or financial instruments convertible into shares or to conduct a further capital increase of 180 days, subject to customary exceptions.
 

Important notice

The distribution of this announcement and the offering of the shares of Gerresheimer AG in certain jurisdictions may be restricted by law. Persons into whose possession this announcement comes are required to inform themselves about, and to observe, any such restrictions. This announcement does not contain or constitute an offer of, or the solicitation of an offer to buy or subscribe for, securities to any person in the United States of America, Australia, Canada, Japan or in any jurisdiction to whom or in which such offer or solicitation is unlawful.

Securities may not be offered or sold absent registration except pursuant to an exemption from, or a transaction not subject to, the registration requirements under the U.S. Securities Act of 1933, as amended. There will be no public offer of securities in the United States of America or in any other jurisdiction.

In member states of the European Economic Area ("EEA"), this announcement is only addressed to and directed at persons who are 'qualified investors' within the meaning of Article 2(e) of the Prospectus Regulation (Regulation (EU) 2017/1129) (as amended, the "Prospectus Regulation") ("Qualified Investors"). In the United Kingdom, this announcement is only addressed to and directed at Qualified Investors who are persons (i) who have professional experience in matters relating to investments falling within Article 19(5) (investment professionals) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the "Order") or (ii) falling within Article 49(2)(a) to (d) (high net worth companies, incorporated associations, etc.) of the Order.

To the extent this announcement contains predictions, expectations or statements, estimates, opinions and projections with respect to anticipated future performance of Gerresheimer AG (“forward-looking statements”), they are based upon current views and assumptions of the Gerresheimer AG management, which were made to its best knowledge. Forward-looking statements reflect various assumptions taken from Gerresheimer AG's current business plan or from public sources which have not been independently verified or assessed by Gerresheimer AG and which may or may not prove to be correct. Forward-looking statements are subject to known and unknown risks, uncertainties and other factors which could cause the earnings position, profitability, performance or the results of Gerresheimer AG or the success of the industries in which Gerresheimer AG operates to differ materially from the earnings position, profitability, performance or the results expressly or implicitly assumed or described in these forward-looking statements. In consideration of these risks, uncertainties and other factors, persons receiving this document are advised not to rely on these forward-looking statements. Gerresheimer AG does not assume any liability or guarantee for such forward-looking statements and will not adjust them to any future results and developments.

Information to Distributors

Pursuant to EU product governance requirements, the shares have been subject to a product approval process, under which each distributor has determined that such shares are: (i) compatible with an end target market of retail investors and investors who meet the criteria of professional clients and eligible counterparties, each as defined in MiFID II; and (ii) eligible for distribution through all distribution channels as are permitted by MiFID II. Any distributor subsequently offering the shares is responsible for undertaking its own target market assessment in respect of the shares and determining appropriate distribution channels.
 

— Ends —

 

Contact Press

Ueli Utzinger

Group Senior Director Marketing & Communications

Phone: +41 79 400 86 40

[email protected]

 

Contact Investor Relations

Carolin Nadilo

Corporate Senior Director Investor Relations

Phone: +49 211 6181-220

[email protected]

 

Christian Lösse

Senior Manager

Investor Relations

Phone: +49 211 61 81-314

[email protected]

 



End of Inside Information

18-Apr-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Gerresheimer AG
Klaus-Bungert-Str. 4
40468 Düsseldorf
Germany
Phone: +49-(0)211/61 81-314
Fax: +49-(0)211/61 81-121
E-mail: [email protected]
Internet: http://www.gerresheimer.com
ISIN: DE000A0LD6E6
WKN: A0LD6E
Indices: MDAX (Aktie)
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1610761

 
End of Announcement EQS News Service

1610761  18-Apr-2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1610761&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 1.348,25 1.367,73 1.392,26 1.418,79 1.498,01 1.817,09 1.990,49
EBITDA1,2 310,83 298,60 400,01 310,14 306,31 340,87 399,42
EBITDA-Marge3 23,05 21,83 28,73 21,86 20,45 18,76
EBIT1,4 180,80 139,46 123,76 156,46 147,44 169,31 213,39
EBIT-Marge5 13,41 10,20 8,89 11,03 9,84 9,32 10,72
Jahresüberschuss1 103,05 131,13 82,68 89,88 87,24 102,19 120,09
Netto-Marge6 7,64 9,59 5,94 6,33 5,82 5,62 6,03
Cashflow1,7 219,16 173,47 192,92 222,19 212,08 221,94 294,34
Ergebnis je Aktie8 3,21 4,11 2,57 2,82 2,67 3,06 3,48
Dividende8 1,10 1,15 1,20 1,25 1,25 1,25 1,05
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: Deloitte

INVESTOR-INFORMATIONEN
©boersengefluester.de
Gerresheimer
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A0LD6E 107,100 Halten 3.699,23
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
23,28 24,07 0,97 32,51
KBV KCV KUV EV/EBITDA
2,64 12,57 1,86 11,58
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
1,25 1,25 1,17 05.06.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
11.04.2024 11.07.2024 10.10.2024 22.02.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
14,72% 6,80% 13,51% 23,10%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Gerresheimer AG  ISIN: DE000A0LD6E6 können Sie bei EQS abrufen


Oberflächen/Verpackung , A0LD6E , GXI , XETR:GXI